It also upregulates BDNF levels in the hippocampus and cerebral cortex of mice and decreases the transport of NF-κB p65 and the binding activity of NF-κB in the nucleus.[56] These mechanisms play an important role in improving depression-like behavior by isorhynchophylline. Here, NFKB1 is linked to depressive symptom measurement.